Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

One of the big problems with pancreatic cancer is that its early symptoms are very easy to miss. They often look like signs ...

and they significantly slowed down tumor growth in a study of mice. “Pancreas cancer is one of the most challenging cancers to treat. This study identifies an unexpected vulnerability in ...

Pasithea shares rise as early Phase 1 data of PAS-004 shows strong pERK inhibition and tumor shrinkage in advanced cancer ...

Announcing a new publication for Acta Materia Medica journal. A preclinical study has developed a precision nano-intervention ...

Orlando Health has unveiled its expanded Digestive Health Institute, now using artificial intelligence for earlier detection ...

When she was told, "It's a pancreatic tumor," Anna was six months pregnant. Her first thought, immediate and devastating, was ...

A study on fasting and the ketogenic diet uncovers a newfound weakness in pancreatic tumors, making them more susceptible to ...

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

Pancreatic cancer remains one of the most formidable oncological challenges of our time. Known for its late detection and ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.